Background and Objectives Upon the encounter of pathogens, dendritic cells (DCs) undergo a process of maturation, which allows them to initiate and orchestrate T-cell-driven immune responses. To avoid random T-cell activation and autoimmunity, respectively, DC maturation has to be tightly controlled. Here we aimed to elucidate the role of 12/15-lipoxygenase (12/15-LO)-mediated enzymatic lipid oxidation during DC-activation/maturation and the fine-tuning of the consecutive T-cell response.
Materials and Methods To delineate the role of 12/15-LO in DCs, we analysed the phenotype of 12/15-/- bone marrow-derived DCs and performed the model of experimental autoimmune enzephalomyelitis (EAE) in wild type and 12/15-LO-/- mice.
Results Differentiated bone marrow-derived DCs expressed 12/15-LO and were enriched in 12/15-LO-specific lipid oxidation products. Deletion of this enzyme resulted in enhanced DC maturation and a shift in their cytokine expression profile, which favoured the differentiation of Th17 T-cells. In contrast, both the activation of DCs and the development of Th17 T-cells were attenuated by exposure to 12/15-LO-derived oxidised phospholipids. The analysis of the lymphatic tissues of 12/15-LO-deficient mice confirmed an enhanced maturation of CD11c+CD11b+CD8- DCs as well as an increased differentiation of Th17 cells that was paralleled by an exacerbation of Th17-driven autoimmune disease.
Conclusions Our data identify 12/15-LO as novel factor modulating the function of DCs and indicate a central, and so far unrecognised, role for enzymatic lipid oxidation during the shaping of the adaptive immune response.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.